News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
637,857 Results
Type
Article (20241)
Company Profile (201)
Press Release (617406)
Multimedia
Podcasts (55)
Webinars (13)
Section
Business (211711)
Career Advice (718)
Deals (31975)
Drug Delivery (50)
Drug Development (64462)
Employer Resources (58)
FDA (13419)
Job Trends (11716)
News (300317)
Policy (23180)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (1517)
Accelerated approval (33)
ADA (26)
Adcomms (2)
Allergies (161)
Alliances (47185)
ALS (151)
Alzheimer's disease (1301)
Antibody-drug conjugate (ADC) (420)
Approvals (14151)
Artificial intelligence (725)
ASCO (208)
Autoimmune disease (284)
Automation (61)
Bankruptcy (298)
Best Places to Work (9336)
BIO (51)
Biologics (2)
BIOSECURE Act (7)
Biosimilars (138)
BioSpace Insights (96)
Biotechnology (137)
Bladder cancer (174)
Brain cancer (53)
Breast cancer (645)
Cancer (5042)
Cardiovascular disease (329)
Career advice (619)
Career pathing (13)
CAR-T (317)
CDC (12)
Celiac Disease (1)
Cell therapy (822)
Cervical cancer (46)
Clinical research (57385)
Collaboration (2083)
Commercialization (5)
Company closure (1)
Compensation (1523)
Complete response letters (41)
COVID-19 (1503)
CRISPR (117)
C-suite (1128)
Cystic fibrosis (114)
Data (7291)
Decentralized trials (2)
Denatured (28)
Depression (123)
Dermatology (79)
Diabetes (460)
Diagnostics (6576)
Digital health (67)
Diversity (7)
Diversity, equity & inclusion (12)
Drug discovery (319)
Drug pricing (24)
Drug shortages (7)
Duchenne muscular dystrophy (204)
Earnings (84807)
Editorial (11)
Employer branding (9)
Employer resources (53)
Events (108725)
Executive appointments (1025)
FDA (17052)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (30)
Funding (1582)
Gene editing (243)
Generative AI (54)
Gene therapy (585)
GLP-1 (502)
Government (1837)
Grass and pollen (4)
Guidances (357)
Healthcare (14450)
Hematology (125)
HIV (71)
Huntington's disease (28)
IgA nephropathy (78)
Immunology and inflammation (140)
Immuno-oncology (72)
Indications (196)
Infectious disease (1788)
Inflammatory bowel disease (161)
Inflation Reduction Act (6)
Influenza (126)
Intellectual property (317)
Interviews (84)
IPO (15041)
IRA (10)
Job creations (2752)
Job search strategy (555)
JPM (22)
Kidney cancer (19)
Labor market (27)
Layoffs (178)
Leadership (8)
Legal (6032)
Licensing (11)
Liver cancer (73)
Longevity (30)
Lung cancer (627)
Lymphoma (369)
Machine learning (57)
Management (20)
Manufacturing (985)
Marketing (10)
MASH (141)
Medical device (13708)
Medtech (13945)
Mergers & acquisitions (18237)
Metabolic disorders (945)
mRNA (200)
Multiple sclerosis (138)
NASH (7)
Neurodegenerative disease (336)
Neuropsychiatric disorders (55)
Neuroscience (2494)
NextGen: Class of 2026 (5053)
Non-profit (2030)
Now hiring (20)
Obesity (308)
Opinion (119)
Ovarian cancer (199)
Pain (215)
Pancreatic cancer (281)
Parkinson's disease (302)
Partnered (26)
Patents (614)
Patient recruitment (710)
Peanut (61)
People (53306)
Pharmaceutical (40)
Pharmacy benefit managers (13)
Phase 1 (19058)
Phase 2 (25545)
Phase 3 (17322)
Pipeline (9624)
Policy (79)
Postmarket research (1743)
Preclinical (8216)
Press Release (69)
Prostate cancer (272)
Psychedelics (10)
Radiopharmaceuticals (321)
Rare diseases (794)
Real estate (4881)
Recruiting (25)
Regulatory (19666)
Reports (28)
Research institute (1586)
Resumes & cover letters (107)
Rett syndrome (48)
RNA editing (19)
RSV (66)
Schizophrenia (119)
Series A (282)
Series B (199)
Service/supplier (6)
Sickle cell disease (83)
Special edition (1)
Spinal muscular atrophy (106)
Sponsored (27)
Startups (3312)
State (2)
Stomach cancer (4)
Supply chain (80)
Tariffs (12)
The Weekly (25)
Vaccines (715)
Venture capital (68)
Weight loss (114)
Women's health (109)
Worklife (4)
Date
Today (68)
Last 7 days (322)
Last 30 days (2111)
Last 365 days (25227)
2026 (16643)
2025 (25286)
2024 (30137)
2023 (34770)
2022 (45222)
2021 (48757)
2020 (45682)
2019 (36479)
2018 (27358)
2017 (27268)
2016 (26287)
2015 (32791)
2014 (27800)
2013 (23780)
2012 (25736)
2011 (26067)
2010 (24909)
Location
Africa (458)
Alabama (88)
Alaska (6)
Arizona (365)
Arkansas (16)
Asia (33698)
Australia (5295)
California (13692)
Canada (3743)
China (1125)
Colorado (600)
Connecticut (538)
Delaware (323)
Europe (64787)
Florida (2075)
Georgia (448)
Hawaii (4)
Idaho (60)
Illinois (1036)
India (88)
Indiana (444)
Iowa (22)
Japan (592)
Kansas (127)
Kentucky (47)
Louisiana (42)
Maine (39)
Maryland (1526)
Massachusetts (9605)
Michigan (401)
Minnesota (757)
Mississippi (6)
Missouri (150)
Montana (31)
Nebraska (19)
Nevada (132)
New Hampshire (89)
New Jersey (3199)
New Mexico (27)
New York (3461)
North Carolina (1673)
North Dakota (10)
Northern California (6816)
Ohio (389)
Oklahoma (23)
Oregon (30)
Pennsylvania (2623)
Puerto Rico (26)
Rhode Island (51)
South America (733)
South Carolina (90)
South Dakota (1)
Southern California (5628)
Tennessee (199)
Texas (2257)
United States (46992)
Utah (426)
Vermont (2)
Virginia (240)
Washington D.C. (52)
Washington State (1104)
West Virginia (3)
Wisconsin (152)
Wyoming (2)
637,857 Results for "haematologic technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology
June 8, 2026
·
7 min read
Press Releases
Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology
March 20, 2026
·
9 min read
Press Releases
PharmaEssentia Announces Publication of Phase 3 SURPASS-ET Results in The Lancet Haematology
November 24, 2025
·
7 min read
Press Releases
CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology
October 7, 2025
·
4 min read
Press Releases
Roche to present new data from its broad and innovative haematology portfolio at ASH 2025
November 4, 2025
·
19 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Drug Development
HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology
HUTCHMED Limited announces that results from ESLIM-01, HUTCHMED’s Phase III trial of sovleplenib, in adult patients with primary immune thrombocytopenia in China, were published in The Lancet Haematology.
June 16, 2024
·
9 min read
Press Releases
Faron Announces Publication of Full Phase I BEXMAB Study Data in Lancet Haematology
May 30, 2025
·
6 min read
Press Releases
Retham Technologies Launches Functional Cryopreserved Platelets for Research; Prolytix Named Distributor of Retham Cryoplatelets™
July 8, 2026
·
2 min read
Press Releases
bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD
July 22, 2026
·
8 min read
1 of 63,786
Next
